Synchronous cancer

Show results for

Unknown (1292)
Proteomics (244)
Genomics (170)
Transcriptomics (104)
Clinical (65)
Models (3)
Genomic (3)
Methylation profiling (2)
Other (2)
Metabolomics (2)

Organisms

Acidithiobacillus ferrooxidans ATCC 53993 (241)
Aerococcus urinae NBRC 15544 = CCUG 36881 (241)
Allexis (241)
Arabidopsis thaliana (241)
Cyanophora paradoxa (241)
Ensifer adhaerens (241)
Enterococcus faecalis (241)
Globicatella sanguinis (241)
Histomonas meleagridis (241)
Leishmania major strain Friedlin (241)
Listeria monocytogenes (241)
Lotus japonicus (241)
Marchantia polymorpha (241)
Medicago truncatula (241)
Methylohalobius crimeensis 10Ki (241)
Mus musculus (241)
Homo sapiens (144)
Mus musculus (11)
Caenorhabditis elegans (7)
Halobacterium salinarum (4)
Saccharomyces cerevisiae (4)
Danio rerio (3)
synthetic construct (2)
Toxoplasma gondii (1)
Schizosaccharomyces pombe (1)
Mycobacterium tuberculosis (1)
Oncorhynchus mykiss (1)
Plasmodium falciparum (1)
Rattus norvegicus (1)
human lung metagenome (1)

Organisms

Homo sapiens (73)
Mus musculus (3)
Saccharomyces cerevisiae (2)
Homo sp. (1)
human lung metagenome (1)
Schizosaccharomyces pombe (1)

Repository

pride (241)
ENA (100)
biostudies-arrayexpress (90)
EGA (48)
geo (38)
dbGaP (3)
Cell Collective (2)
EVA (2)
MassIVE (2)
MetaboLights (2)
BioModels (1)
jPOST (1)

Tissue

Cell culture (135)
Epithelial cell (27)
Cell suspension culture (8)
Colon (8)
Kidney (6)
B cell (5)
Liver (5)
Permanent cell line cell (4)
Spleen (4)
Blood (3)
Brain (3)
Breast (3)
Leukocyte (3)
Lung (3)
Lymph node (3)
Plasma cell (3)
T cell (3)
Breast cancer cell (2)
Embryonic stem cell (2)
Hepatocyte (2)
Intestinal epithelial cell (2)
Intestinal epithelium (2)
Intestine (2)
Mammary gland epithelial cell (2)
Melanocyte (2)
Melanoma cell line (2)
Monocyte (2)
Neuron (2)
Pancreatic ductal cell (2)
Testis (2)

Disease

Colorectal Neoplasms (26)
Neoplasm Metastasis (6)
Neoplasms (5)
Colorectal cancer (3)
StageII colorectal cancer (2)
Carcinoma (2)
Squamous cell carcinoma (1)
Locally advanced rectal cancer (1)
Prostate cancer (1)
Predictive Cancer Model (1)
Krukenberg Tumor (1)
Rectal cancer metastatic (1)
Liver metastases (1)
Unresectable Stage IV colorectal cancer and a synchronous symptomatic primary tumor (1)
Unresectable Stage IV colorectal cancer and a synchronous asymptomatic primary tumor (1)
Optimization of Treatment (1)
Synchronous metastatic liver tumors of colorectal cancer (1)
Synchronous peritoneal metastasis in colorectal cancer (1)
Colorecal cancer (1)
Colorectal liver metastases (1)
Synchronous metastatic colorectal cancer (1)
Obstructive colorectal cancer (1)
Malignant neoplasm of stomach (1)
Obstructive colorectal cancer (1)
Colorectal cancer with synchronous liver metastasis (1)
Carcinoma, Renal Cell (1)
Colorectal cancer gastric cancer (1)
Synchronous peritoneal metastasis from colorectal cancer (1)
Colorectal Cancer (1)
Colorectal cancer (1)

Technology Type

Mass Spectrometry (241)
Shotgun proteomics (187)
Bottom-up proteomics (39)
Data-dependent acquisition (25)
Affinity purification coupled with mass spectrometry proteomics (13)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (2)
Gel-based experiment (2)
Top-down proteomics (2)
Illumina HiSeq 2500 (ILLUMINA) (1)
Illumina MiSeq, Illumina HiSeq 2000, Illumina HiSeq 2500 (1)
ILLUMINA, Illumina HiSeq 2000 (1)
Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2000 (1)
Mass spectrometry (1)
Mass spectrometry assay (1)
SWATH MS (1)

Instrument Platform

NextSeq 550 (3)
Illumina HiSeq 2500 (3)
NextSeq 500 (3)
Illumina NovaSeq 6000 (2)
10X Genomics Chromium v3.1 with multiplexing kit (1)
Chemostat (1)
Illumina Hiseq Xten (1)
- (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2021 (58)
2022 (50)
2023 (33)
2020 (30)
2025 (27)
2024 (23)
2026 (22)
2010 (17)
2019 (16)
2018 (16)
2014 (15)
2011 (12)
2015 (11)
2013 (10)
2008 (9)
2017 (8)
2012 (8)
2016 (4)
2009 (3)
2007 (3)
2005 (1)
2006 (1)

CHEBI ID

CHEBI:28683 (1)
CHEBI:27897 (1)

Metabolite Name

Tryptophan (1)
Kynurenine (1)
Urocanic acid (1)
Threonylproline (1)
Sphinganine (1)
Spermidine (1)
Serylmethionine (1)
PC(O-38:6) (1)
PC(O-34:2) (1)
PC(O-34:1) (1)
PC(O-32:1) (1)
PC(38:6) (1)
PC(38:3) (1)
PC(36:3) (1)
PC(36:1) (1)
PC(34:3) (1)
PC(34:1) (1)
PC(32:1) (1)
PC(32:0) (1)
PC(30:0) (1)
Oleoylcarnitine (1)
Octanoylcarnitine (1)
N'-Formylkynurenine (1)
N-Acetylserotonin (1)
N-Acetylputrescine (1)
N1-Acetylspermine (1)
Myristoylcarnitine (1)
Methylthioadenosine (1)
LysoPE(18:2(9Z,12Z)/0:0) (1)
LysoPE(16:1(9Z)/0:0) (1)

First Public Date

2014 (15)
2024 (14)
2019 (11)
2017 (11)
2022 (7)
2015 (7)
2026 (6)
2023 (6)
2020 (6)
2021 (5)
2018 (4)
2016 (4)
2025 (3)
2013 (1)

Modelling Approach

Ordinary differential equation model (1)

Study status

Completed (19)
Recruiting (14)
Not provided (9)
Not yet recruiting (8)
Terminated (7)
Active, not recruiting (3)
Ongoing (2)
Withdrawn (2)
Suspended (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (73)
The Institute of Cancer Research (13)
The Institute of Cancer Research, London (8)
Institute of Cancer Research, London (7)
Wellcome Trust Sanger Institute (6)
Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany Frankfurt Cancer Institute, Frankfurt am Main, Germany Cardio-Pulmonary Institute, Frankfurt am Main, Germany (4)
Center of Human and Molecular Biology (ZHMB), Saarland University School of Medicine, Homburg, Germany (3)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA (3)
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA (2)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (2)
Functional Proteomics, ICR (2)
Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. The Center for Functional Proteomics, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. Frankfurt Cancer Institute, Frankfurt am Main, Germany. Cardio-Pulmonary Institute, Frankfurt am Main, Germany. (2)
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany German Cancer Consortium (DKTK) Mainz/Frankfurt, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany (2)
1. Centre for Genomic Regulation, Dr Aiguader 88, 08003 Barcelona, Spain 2. Universitat Pompeu Fabra, Dr Aiguader 88, 08003 Barcelona, Spain (1)
1. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 2. Arkansas Children's Research Institute (1)
1Department of Biochemistry and Biophysics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States (1)
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA 2Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA (1)
Assistant Professor of Pediatrics Assistant Professor of Pharmacology & Toxicology Indiana University School of Medicine (1)
Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (1)
Bioscience Institute,Faculty for Medical Sciences at Newcastle University. Newcastle-Upon-Tyne United Kingdom NE24HH (1)
Bruce M. Spiegelman, Ph D. Stanley J. Korsmeyer Professor of Cell Biology and Medicine Dana-Farber Cancer Institute, Harvard Medical School bruce_spiegelman@dfci.harvard.edu 617-632-3567 (1)
Cancer Biology Department, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA. (1)
Cancer Research UK University of Cambridge Li Ka Shing Centre Robinson Way Cambridge, CB2 0RE (1)
Cancer Research UK, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE (1)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria (1)
Cellular and Systems Medicine, Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Dundee. DD1 9SY, UK (1)
Centre For Targeted Protein Degradation (CeTPD) University of Dundee 1 Lindsay Place, DD1 5JJ Dundee, UK (1)
Dalhousie University (1)
Debora Bonenfant, Novartis Institutes for Biomedical Research, Basel, Switzerland (1)
Debora Bonenfant, Novartis Institutes for Biomedical research, Basel, Switzerland (1)

Keyword

Liver metastases (4)
Chemotherapy (4)
Oxaliplatin (4)
Liver Extracts (3)
Primary tumor resection (3)
Irinotecan (3)
Bevacizumab (3)
HIPEC (2)
Hepatectomy (2)
Liver resection (2)
Metastasis (2)
Capecitabine (2)
Leucovorin (2)
Cetuximab (2)
Synchronous multiple primary colorectal cancer (1)
Neoadjuvant treatment (1)
Phenotype (1)
Genetic mutation (1)
Metachronous lesions (1)
Pre-operation chemotherapy (1)
Diffusion Weighted MRI (1)
Neoplasms, Rectal (1)
Tumor evolution (1)
Controlled clinical trial (1)
Unresectable colorectal liver metastases (1)
FLUOROURACILE ICN (1)
IRINOTECAN MAYNE (1)
Primary focus (1)
Heterogeneous metastasis (1)
Synchronous carcinoma (1)

IsPrivate

False (1)

Model Flag

Sbml Extended (1)
Non Kinetic (1)

Modification

2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)

Study type

Transcription profiling by array (59)
Interventional (44)
Observational (16)
Comparative genomic hybridization by array (6)
Unknown experiment type (4)
ChIP-seq (3)
RNA-seq of coding RNA (3)
Observational patient registry (3)
Other (2)
Methylation profiling by array (2)
RNA-seq of coding RNA from single cells (2)
RNA-seq of total RNA (2)
RNA-seq of non coding RNA (2)
Other (2)
Human - High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Genotyping by array (1)
ATAC-seq (1)
Exome sequencing (1)

Release Date

2022 (178)
2023 (171)
2024 (135)
2025 (134)
2021 (131)
2020 (117)
2019 (90)
2018 (69)
2016 (59)
2017 (52)
2015 (51)
2014 (48)
2013 (24)
2010 (24)
2026 (23)
2012 (21)
2011 (19)
2008 (12)
2009 (11)
2007 (5)
2004 (3)
2005 (2)
2000 (2)
2006 (1)

Location

China (12)
Japan (8)
France (5)
United Kingdom (4)
Italy (4)
Germany (4)
Netherlands (4)
Denmark (3)
Spain (3)
Canada (2)
United States (2)
Vietnam (1)
Thailand (1)
Slovenia (1)
Singapore (1)
Asia except Japan (1)
Russia (1)
South Korea (1)
Czechia (1)
Sweden (1)

Previous page
1 / 189
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 189
Next page

Sort by:

Relevance

Page size

Spatial and Untargeted Metabolomics Define Location- and Histology-Specific Metabolic Reprogramming in Colorectal Cancer

Colorectal cancer (CRC) exhibits profound molecular heterogeneity based on primary tumor location. A comprehensive understanding of the spatially resolved metabolic differences between right-sided (RCC) and left-sided (LCC) carcinomas remains elusive. Here, to eliminate the influence of inter-ind...

2026-03-24 | MTBLS13729 | MetaboLights

A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer

Purpose: Increasing genomics-based evidence suggests that synchronous endometrial and ovarian cancer (SEOC) represents clonally related primary and metastatic tumors. A systematic analysis of the global protein landscape of SEOCs, heretofore lacking, could reveal functional and disease-specific cons...

ORGANISM(S): Homo sapiens (Human)

2025-03-11 | PXD059172 | Pride

Proteome analysis of human serum from the esophageal cancer patient before preoperative chemoradiotherapy

To identify a biomarker that can predict the response of preoperative chemoradiotherapy (PCRT). Twenty-five serum samples from patents with esophageal cancer before PCRT (responder = 13, non-responder = 12) were analyzed by quantitative proteomics.

ORGANISM(S): Homo Sapiens (human)

2020-02-21 | PXD012819 | JPOST Repository

A microRNA and snoRNA expression profile in the synchronous colorectal cancer

We evaluated the profile of miRNA and snoRNA expression in 5 synchronous CRC and matched normal colorectal tissues using the Affymetrix GeneChip miRNA 1.0 array. A total of 24 miRNA differential expressed transcripts which represent 27 mature miRNAs, including an oncogenic miR-17-92a and oncosuppres...

ORGANISM(S): Homo sapiens

2015-08-01 | E-GEOD-54632 | biostudies-arrayexpress

Redefining synchronous colorectal cancer on the basis of clonality

PRJNA432579 | ENA

How to manage synchronous endometrial and ovarian cancer patients?

Not available

S-EPMC8088669 | biostudies-literature

A microRNA and snoRNA expression profile in the synchronous colorectal cancer

ORGANISM(S): Homo sapiens synthetic construct

2015-08-01 | GSE54632 | GEO

geneplus-multifocal synchronous lung cancer

Genomic heterogeneity of multifocal synchronous lung cancer with diversely pathological subtypes